Latest Intelligence on Medical Devices and Diagnostics in Europe

Published within

« | 1 | 2 | 3 | » »|

Type Product title / description Pub Price
Expert View
Expert View

APA 2010: unmet needs in major depressive disorder remain key

Key themes presented in the field of major depressive disorder at this year's American Psychiatric Association annual meeting included treatment-resistant depression, transcranial magnetic stimulation and adjunctive use of antipsychotics. While no new clinical trial data were presented, those that were provide an interesting insight into the strategies of a number of major pharmaceutical players.

Published By Datamonitor
10 Jun 2010
Expert View
Expert View

AstraZeneca and Boehringer Ingelheim steal limelight at European Society of Cardiology meeting

Well crafted, positive results for AstraZeneca's Brilinta and an unexpected coup for Boehringer Ingelheim's Pradaxa dominated the headlines following this year's European Society of Cardiology's Annual Meeting in Barcelona. Both announcements have a number of important implications for the wider cardiology market, from both therapeutic and commercial perspectives.

Published By Datamonitor
03 Sep 2009
Expert View
Expert View

ATS 2010: developments in IPF and cystic fibrosis

The FDA's recent refusal of Esbriet and the publication of new guidelines for the treatment of idiopathic pulmonary fibrosis drove considerable interest in this disease at the 2010 meeting of the American Thoracic Society. Furthermore, the approval of the first new inhaled antibiotic for cystic fibrosis in over a decade brought renewed focus on this rare but extremely debilitating disease.

Published By Datamonitor
04 Jun 2010
Expert View
Expert View

ATS 2010: shift in asthma guidelines highlights focus on personalized medicine

Datamonitor attended this year's meeting of the American Thoracic Society in New Orleans. The 2010 conference was defined not only by the latest clinical trial data, but by new guidelines and an emerging discussion of the role of personalized treatment. Conclusions were also presented from the ISAAC study, highlighting some surprising global prevalence trends.

Published By Datamonitor
04 Jun 2010
ResearchWire
ResearchWire

Bone graft substitutes: European sales more than $52 million by 2005

Published By Datamonitor
15 May 2001
CommentWire
CommentWire

DePuy/BTG: orthopedic powerhouse to drive hyaluronic acid

Published By Datamonitor
08 Aug 2001
ResearchWire
ResearchWire

European spine market: slow growth to 2003

Published By Datamonitor
30 Jul 2001
ResearchWire
ResearchWire

French hip implants: metal-on-metal to rock the market

Published By Datamonitor
20 Jul 2001
ResearchWire
ResearchWire

German hip implants: ceramic-on-ceramic to take quarter of market

Published By Datamonitor
03 Jul 2001
CommentWire
CommentWire

Hip implants: second recall in nine months

Published By Datamonitor
20 Sep 2001

« | 1 | 2 | 3 | » »|

No help is available.